356 related articles for article (PubMed ID: 10559833)
21. Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family.
Forte LR; Eber SL; Fan X; London RM; Wang Y; Rowland LM; Chin DT; Freeman RH; Krause WJ
Endocrinology; 1999 Apr; 140(4):1800-6. PubMed ID: 10098518
[TBL] [Abstract][Full Text] [Related]
22. Opossum colonic mucosa contains uroguanylin and guanylin peptides.
Hamra FK; Krause WJ; Eber SL; Freeman RH; Smith CE; Currie MG; Forte LR
Am J Physiol; 1996 Apr; 270(4 Pt 1):G708-16. PubMed ID: 8928802
[TBL] [Abstract][Full Text] [Related]
23. Expression of the receptor guanylyl cyclase C and its ligands in reproductive tissues of the rat: a potential role for a novel signaling pathway in the epididymis.
Jaleel M; London RM; Eber SL; Forte LR; Visweswariah SS
Biol Reprod; 2002 Dec; 67(6):1975-80. PubMed ID: 12444076
[TBL] [Abstract][Full Text] [Related]
24. High salt intake increases uroguanylin expression in mouse kidney.
Potthast R; Ehler E; Scheving LA; Sindic A; Schlatter E; Kuhn M
Endocrinology; 2001 Jul; 142(7):3087-97. PubMed ID: 11416031
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of actions of guanylin peptides in the kidney.
Sindić A; Schlatter E
Pflugers Arch; 2005 Aug; 450(5):283-91. PubMed ID: 15952032
[TBL] [Abstract][Full Text] [Related]
26. Guanylyl cyclase receptors and guanylin-like peptides in reptilian intestine.
Krause WJ; Freeman RH; Eber SL; Hamra FK; Currie MG; Forte LR
Gen Comp Endocrinol; 1997 Aug; 107(2):229-39. PubMed ID: 9245531
[TBL] [Abstract][Full Text] [Related]
27. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
[TBL] [Abstract][Full Text] [Related]
28. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone.
Greenberg RN; Hill M; Crytzer J; Krause WJ; Eber SL; Hamra FK; Forte LR
J Investig Med; 1997 Jun; 45(5):276-82. PubMed ID: 9250001
[TBL] [Abstract][Full Text] [Related]
30. Guanylin stimulation of Cl- secretion in human intestinal T84 cells via cyclic guanosine monophosphate.
Forte LR; Eber SL; Turner JT; Freeman RH; Fok KF; Currie MG
J Clin Invest; 1993 Jun; 91(6):2423-8. PubMed ID: 8390480
[TBL] [Abstract][Full Text] [Related]
31. Guanylin and related peptides.
Bełtowski J
J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
[TBL] [Abstract][Full Text] [Related]
32. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
[TBL] [Abstract][Full Text] [Related]
33. Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.
Uranga JA; Castro M; Abalo R
Curr Med Chem; 2018; 25(16):1879-1908. PubMed ID: 29210639
[TBL] [Abstract][Full Text] [Related]
34. Guanylin in the human pancreas: a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and CFTR in the ductal system.
Kulaksiz H; Schmid A; Hönscheid M; Eissele R; Klempnauer J; Cetin Y
Histochem Cell Biol; 2001 Feb; 115(2):131-45. PubMed ID: 11444148
[TBL] [Abstract][Full Text] [Related]
35. The intestinal guanylin system and seawater adaptation in eels.
Takei Y; Yuge S
Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
[TBL] [Abstract][Full Text] [Related]
36. Pendrin, a novel transcriptional target of the uroguanylin system.
Rozenfeld J; Tal O; Kladnitsky O; Adler L; Efrati E; Carrithers SL; Alper SL; Zelikovic I
Cell Physiol Biochem; 2013; 32(7):221-37. PubMed ID: 24429828
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
[TBL] [Abstract][Full Text] [Related]
38. Guanylin-like peptides, guanylate cyclase and osmoregulation in the European eel (Anguilla anguilla).
Kalujnaia S; Wilson GD; Feilen AL; Cramb G
Gen Comp Endocrinol; 2009 Mar; 161(1):103-14. PubMed ID: 19028495
[TBL] [Abstract][Full Text] [Related]
39. Renal electrolyte effects of guanylin and uroguanylin.
Sindić A; Schlatter E
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
[TBL] [Abstract][Full Text] [Related]
40. E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.
Giannella RA; Mann EA
Trans Am Clin Climatol Assoc; 2003; 114():67-85; discussion 85-6. PubMed ID: 12813912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
